Alset Inc. AEI Biohealth Business — Other General Expense
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Alset Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherGeneralExpense.
The official record: Alset Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Alset Inc.'s biohealth business — other general expense.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Alset Inc.'s biohealth business — other general expense?
- Alset Inc. (AEI) reported biohealth business — other general expense of $97.62K in Q1 2026.
- How has Alset Inc.'s biohealth business — other general expense changed year-over-year?
- Alset Inc.'s biohealth business — other general expense decreased by 81.0% year-over-year, from $512.93K to $97.62K.
- What is the long-term trend for Alset Inc.'s biohealth business — other general expense?
- Over 2 years (2021 to 2025), Alset Inc.'s biohealth business — other general expense has grown at a -36.2% compound annual growth rate (CAGR), from $3.62M to $1.48M.
- What does biohealth business — other general expense mean?
- Represents the administrative and overhead costs incurred by the biohealth business segment that are not directly attributable to production or sales. These expenses typically include management salaries, office rent, and general corporate support functions necessary to maintain segment operations.